A monoclonal antibody (against 7A antigen), raised against a homogenate of embryonic rat forebrain, marks the distribution of region-and developmental stage-specific cell-surface antigens in the mammalian central nervous system. In the mouse, immunocytochemical staining revealed that 7A antigen is expressed almost exclusively in germinal layers of the cerebral cortex beginning as early as day 11 of gestation and becomes undetectable by birth. The typical staining is seen at embryonic days 13-15, in which only the ventricular and the subventricular zones of the cerebral cortex are intensely labeled, whereas most other areas of the brain are unlabeled. Tissue culture studies indicate that the 7A antigen is localized at the plasma membrane. Molecular species possessing the antigen are identified as neutral glycolipids that contain the X-determinant trisaccharide:
The nervous system develops through a sequence of cellular events, including cell proliferation, migration to particular sites, and various states of morphological differentiation leading to the establishment of the specific afferent and efferent connections. A general hypothesis is that these events are regulated by the interaction of molecules expressed on cell surfaces, in the extracellular matrix, or by diffusable substances. There is increasing evidence that certain glycoproteins are involved in specific cell-cell interactions in the development of the peripheral nervous system. For example, the glycoproteins N-CAM (neural cell adhesion molecule) and fibronectin undergo reciprocal changes in expression in association with the migration of neural crest cells and their aggregation into ganglia (1, 2) . In vitro experiments suggest a causal role of N-CAM in promoting cell-cell adhesion (3, 4) and for fibronectin in stimulating migration (5) . Temporal and spatial changes in the expression of these two glycoproteins in the central nervous system (CNS) suggest that they may play a comparable role in the control of migration and settling of granule cells of the cerebellum (6) .
Glycolipids are an alternative candidate for glycoconjugate molecules mediating developmental interactions. Expression of glycolipids also appears to correlate with differentiation of embryonic cells and tumor cells in culture (7) . In the development of the nervous system, however, detailed studies of glycolipid expression are just beginning to emerge. Studies of acidic glycosphingolipids (gangliosides) have shown that there are definite correlations between the expression of gangliosides GM3 and GD3 (monosialo and disialo derivatives of lactosylceramide, respectively) and CNS development (8) . In the developing cerebellum, ganglioside GM1 increases during development of granule cell neurons (9) . Results using anti-ganglioside monoclonal antibodies for immunohistochemical studies of mammalian CNS suggest that both GD3 ganglioside (10) and D1-1 ganglioside (11) , which contains O-acyl sialic acid (33) , are associated with undifferentiated cells in early postnatal cerebellum. However, the significance of these correlations is not clear, and the function of gangliosides in the CNS has remained ambiguous. Some recent studies indicate that gangliosides may be involved in cell-cell interactions in the CNS. GM2 has been proposed to play a role in adhesive interactions in the chicken retino-tectal projection (12) .
In contrast to these promising studies of developmental changes in ganglioside expression, very few neutral glycolipids other than galactosylceramide have been identified in embryonic or adult CNS, either chemically or immunologically (13, 14) . In this paper, we report that a monoclonal antibody produced against embryonic brain, which recognizes neutral glycolipids that express the Xdeterminant trisaccharide, labels the surface of a distinct class of cells in the developing cerebral cortex and reacts with few noncortical cells in the embryonic brain. These glycolipids are expressed mainly on proliferating cells, which are precursors of both neurons and glia, but not on migrating or postmigratory cells. This suggests that the expression of these glycolipids may modulate the cell-cell interactions in the normal developmental processes in particular regions of the brain.
MATERIALS AND METHODS
Hybridoma Production. BALB/c mice were immunized three times at 2-wk intervals with the homogenate obtained from embryonic rat forebrain. Three days after the final injection, mice were sacrificed and spleen cells were fused with the myeloma cell line (NS-1) as described (15) . Supernatants from 96-well plates were screened on tissue sections of embryonic brain prepared as described below. A monoclonal antibody against 7A antigen was obtained. The subclass was identified as IgM by using subclass-specific secondary antibody.
Materials. Sprague-Dawley rats and C3B6 mice were used.
Mice were mated in our colony, and timed-pregnancy rats were obtained from Charles River Breeding Laboratories. The day of detection of a sperm plug is determined as gestation day [embryonic day 0 (EO)]. For immunocyto-
Abbreviations: E, embryonic day; P, postnatal day; CNS, central nervous system; SSEA-1, stage-specific embryonic antigen 1.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" Western Blotting. Brain homogenate from E13-15 or P14 rats was electrophoresed with NaDodSO4 gel chromatography and blotted onto nitrocellulose paper as described (17) .
The nitrocellulose paper was incubated with 3% normal goat serum and then with anti-7A antibody at 4°C overnight, washed, and incubated at RT for 2-3 hr with peroxidaseconjugated anti-mouse IgM (1:1000 in Pi/NaCl). The reaction product was visualized with 3,3'-diaminobenzidine.
Glycolipid Extraction and Analysis. The chloroform/methanol extracts were dried under nitrogen, resuspended in distilled water, and desalted on Bond-Elut cartridges (18) (Analytical Chemicals, Harbor City, CA). The desalted glycolipids were chromatographed on DEAE-Sephadex A-25 (Pharmacia) to separate neutral glycolipids from gangliosides (19) . Neutral glycolipids were treated with 0.6 M methanolic NaOH for 1 hr at RT, neutralized with 0.5 M HCl, and desalted. The desalted neutral glycolipids were chromatographed on high-performance TLC plates (Merck) in chloroform/methanol/water, 60:35:8 (vol/vol).
Radiolabeling. Cell cultures containing -107 cells were incubated for 18 hr with 100 ,Ci (1 Ci = 37 GBq) of [3H]fucose (New England Nuclear). Cells were then harvested and extracted as above. TLC plates containing radioactively labeled glycolipids were exposed on Ultrafilm (LKB) for 4-14 days at RT.
Immunochromatography. Neutral glycolipids and gangliosides were chromatographed on aluminum high-performance TLC plates (Merck) in chloroform/methanol/water, 60:35:8 (vol/vol), dried, and then dipped in 0.05% poly(isobutyl methacrylate) in hexane as described by Brockhaus et al. (20) . The plates were then soaked in Pi/NaCl containing 1% bovine serum albumin for 2 hr before exposure to anti-7A antibody for 2 hr at 4°C. After the plates were washed in P1/NaCl, they were exposed to goat anti-mouse IgM conjugated to horseradish peroxidase for 2 hr at 4°C. The plates then were washed in Pi/NaCl and developed with 33 mM 4-chloronaphthol in 0.02 M Tris HCl buffer containing 20% methanol and 0.025% H202.
Immunoprecipitation. Immunoprecipitation was carried out as described (21) . Briefly, 107 cells were labeled with 400 ,Ci of [35S]methionine for 2 hr at 37°C. After being washed, the cells were lysed in 0.01 M Tris in P1/NaCl containing 1% Trasylol, 0.1 mM phenylmethylsulfonyl fluoride, 0.05% NaDodSO4, and 1% Triton X-100. Lysates containing 106
cpm of radioactivity were incubated with 50 ,ul of purified anti-7A antibody overnight at 4°C, followed by 50 ,ul of rabbit anti-mouse IgM and 50 /ul of Pansorbin (Calbiochem-Behring). After the precipitate was washed several times, it was boiled for 2 min in sample buffer. After removal of the Pansorbin, the supernatant was electrophoresed on NaDodSO4/polyacrylamide gels (22) . Immunoreactive bands were visualized by autoradiography.
RESULTS
Distribution of 7A in the Embryonic Brain. Immunocytochemical studies revealed that the 7A antigen is differentially distributed in the rodent brain from early stages of histogenesis. In the mouse, stages E9 through birth (E19), P21, and adult were examined. Temporal changes in the distribution of the antigen in embryonic mouse brain are summarized in Fig. 1 . The most outstanding feature of the distribution of this antigen is that it is localized almost exclusively in the cerebral cortex from day Eli, particularly in cells of the germinal zones. This staining had a mesh-like appearance which suggests an association with either the plasma membrane or extracellular space (Fig. 2F) . At day E9, the surface of the neural tube showed immunoreactivity. At E10, staining appeared in the lateral wall of the forebrain, the midbrain, and the central portion of the spinal cord. In the period from Eli to E13, the entire lateral wall of the cortical anlage was strongly positive (Fig. 2 A-C caudal gradient in the immunoreactivity in the cortex. The caudal portion was more intensely labeled than was the rostral portion, and the olfactory bulb was devoid of labeling ( Fig. 2A , level e) at these stages. Two small discrete areas, one in the hypothalamic region ( Fig. 2A, level d) and the other in the ventral wall of the inferior colliculus ( Fig. 2A, level a (Fig. 2D) . At E19 (P0) in the mouse, staining in the cortex disappeared entirely. Thereafter, less discrete, more diffuse staining ofthe extracellular compartment began to appear in the thalamus, basal ganglia, medulla, and spinal cord. This reactivity increased and persisted up to the third postnatal week and then gradually decreased. In the rat, the patterns of emergence of immunoreactivity were basically similar to those in the mouse. However, the anlagen of the basal ganglia and the neural retina were strongly immunoreactive from E13 in this animal. Tissue Culture. The immunoreactive cell types and subcellular localization of antigen were assessed by using primary tissue culture obtained from rat embryonic brain. Staining of both living and prefixed cells confirmed that immunoreactivity is localized in the plasma membrane. In cultures prepared from the telencephalon of the E13 rat, about 80-90% of the total cell population was stained with anti-7A antibody 1 hr after dissociation with trypsin and plating ( Fig. 3 A and B) (Fig. 4A) , probably the result of the heterogeneity within the ceramide portion of these molecules bearing the 7A epitope; each doublet in mental time frame, galactosylceramide increased dramatically, while the more complex glycolipids decreased or disappeared. A postnatal decrease in immunoreactive glycolipids was also seen. These anti-7A-reactive glycolipids were detected as early as day Eli in the mouse. In the rat, high concentrations were present in the E15-17 interval, decreased after PO, and became nearly undetectable at P14 (Fig. 4D) .
To determine the carbohydrate structure of these glycolipids, [3H]fucose labeling of dissociated E15-17 brain was carried out. Significant incorporation offucose into three glycolipids (numbered 1-3) that are chromatographically identical to the anti-7A antibody-reactive glycolipids is shown in Fig. 4B . Immunoreactivity of anti-7A is the strongest with the largest fucoglycolipid (no. 3) and weakest with the smallest one (no. 1). This could represent either a cross-reactivity or a preference of the antibody for longerchain structures as has been described (23) . To characterize the carbohydrate structure of anti-7A glycolipids further, immunochromatography was carried out against neutral glycolipid extracted from E15-17 rat brain by using a panel of known fucose-reactive blood group antibodies, including anti-H (24), anti-Lea (Lewisa blood group) (25) and anti-SSEA-1 (stage-specific embryonic antigen 1) (26) . The reactivity of anti-7A antibody with each of these blood group antigens was also tested. From these studies it is clear that anti-SSEA-1, which is known to react with X-determinant glycoconjugates, reacted with the same fucose-containing glycolipid as did anti-7A, and further that anti-7A reacts with III3-a-fucosyl-lactoneotetraglycosylceramide (gift of V. Ginsburg, National Institutes of Health), which is an Xdeterminant glycolipid (data not shown).
DISCUSSION
The most distinctive feature of the antigen is its relatively restricted distribution to the cortical anlage from early embryonic stages to the time of birth. The time course of staining in the cortex suggests that there are two (or more) types of molecules recognized by anti-7A antibody. Staining appears at an early embryonic stage and disappears at birth (Fig. 1) . However, cellular reactivity appears again postnatally in the cortex, at a time when anti-7A-reactive glycolipid has decreased significantly and is probably no longer expressed in the cortex. This indicates that the antibody is probably recognizing multiple molecular species: glycolipid prenatally and glycoprotein or proteoglycan postnatally, all of which may share the same carbohydrate antigenic determinant. Although it is difficult to distinguish each of these glycoconjugates by immunocytochemical staining, immunoreactivity in the embryonic cortex is likely to be mostly due to glycolipid since it remains after trypsin treatment (Fig. 3) . In other areas of the brain, identification of the molecular species of the antigenic determinant may be more difficult. As shown in Fig. 1 , a small portion of both the hypothalamus and the inferior colliculus are immunoreactive at day Eli. This reactivity continues throughout prenatal and postnatal development. The early staining in these noncortical areas is probably partly due to glycolipid expression since it is resistant to trypsin treatment (Fig. 3) . In later stages (around day E17), when diffuse reactions appear in the hippocampus, thalamus, and medulla, it is possible that other X-determinant glycoconjugates are also expressed. The reactivity of the nonneuronal tissue has not been chemically studied to determine whether it is also due to glycolipid.
From the immunochemical comparison of anti-7A and anti-SSEA-1 antibodies, it is apparent that both antibodies recognize the same carbohydrate moiety, the X-determinant. Antibodies to SSEA-1 were first produced by immunization with the teratocarcinoma cell line F9. When first described, Proc. Natl. Acad. Sci. USA 82 (1985) SSEA-1 was believed to be a marker for differentiation of the mouse preimplantation embryo (26) . The antigen appeared at the 8-cell stage, was maximally expressed in the morulae, and disappeared at the blastocyst stage. The carbohydrate specificity of anti-SSEA-1 antibody was determined several years later (27) . Only recently was a group of polydisperse glycoproteins, but not glycolipids, from F9 cells found to react with anti-SSEA-1. In the meantime, it was found that anti-SSEA-1 reacted not only with mouse preimplantation embryonic tissue but also with other fetal and adult mouse and human tissues, including various tumors (28) . 1ecent studies now have shown that glycolipids from human adenocarcinoma (29) and granulocytes (21, 30) possess the Xdeterminant structure and react with anti-SSEA-1 or similar antibodies. To date, though, the molecular nature of the X-determinant glycoconjugates in embryonic tissue remains unknown.
Although anti-7A and anti-SSEA-1 antibodies recognize similar carbohydrate structures, a comparison of their cellular reactivities in neuronal and nonneuronal tissues has revealed a difference. Lagenaur et al. (31) reported that anti-SSEA-1 reacted weakly with germinal cells of embryonic mouse brain. However, the reaction was not specifically localized, as is the case for anti-7A. In postnatal cerebellum (31), anti-SSEA-1 stains the external granule cell layer and prospective white matter in vivo and astrocytes in vitro. Anti-7A shows a similar staining pattern in the postnatal cerebellum, but the reaction is weak compared to the embryonic cortex. Other differences of the immunoreactivity are seen in embryonic nonneuronal tissue. Anti-7A and anti-SSEA-1 both react with epidermis and auditory vesicles. Anti-7A also reacts with nasal epithelium, ocular conjunctivum, bronchial epithelium, and stomach epithelium, but it is not clear whether these tissues are also anti-SSEA-1 positive (32) . The reactivity with F9 seems the same for both antibodies. Thus, the tissue distributions of anti-7A and anti-SSEA-1 are similar but not identical. These differences in tissue reactivity of the two antibodies may be ascribed to slight differences in either specificity or binding affinity but also may be due to differences in staining techniques.
Developmentally regulated gangliosides that have been described previously have not been extensively characterized immunocytochemically in embryonic brain. In the postnatal cerebellar cortex (10, 11) , antibodies to both ganglioside GD3 and D1-1 stain the external granule cell layer. Anti-D1-1 also stains the germinal zones of the embryonic forebrain. Anti-7A recognizes both of these areas; however, the mapping with anti-7A antibody at various stages of development reveals that the antigen is distributed in a very restricted manner to the cortex in the CNS. A further study with these ganglioside antibodies might potentially reveal specific distribution of the antigens.
The work reported here demonstrates that there is a group of fucose-containing glycolipids that is expressed in relatively high concentrations in embryonic rodent brain but disappears shortly after birth (see Fig. 4 ). These glycolipids react by ELISA and immunochromatography equally well with anti-SSEA-1 and anti-7A antibodies. These glycolipids are present in the cortical layers containing proliferative and premigratory cells but not in layers containing migratory and postmigratory cells. We recently have detected these glycolipids in embryonic brain of a number of vertebrates including chicken, rabbit, calf, and human. The existence of X-determinant glycolipids in embryonic and early postnatal tissue from the CNS and the restricted distribution of 7A antigens suggests the possibility that these glycolipids may be specifically involved in normal development of the embryonic cerebral cortex. The function of neutral or acidic glycolipids in these germinal cells is poorly understood but it seems likely that they may mediate a role in cell proliferation or cell-cell interactions.
